ArticleJMIRx med2024

Authors' Response to Peer Reviews of "Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis".

Tigran Makunts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.